Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

2015

The RxPress is the bimonthly newsletter from the University of Illinois Hospital and Health Sciences System Pharmacy Department

Nov-Dec 2015 edition

  • New Analysis of SSRI Use in Pregnancy and Associated Birth Defects
  • Warning Against Combining PDE-5 Inhibitors and Guanylate Cyclase Stimulants
  • Varenicline and Risk of Cardiovascular/Neuropsychiatric Events

Sep-Oct 2015 edition

  • Intracranial hemorrhage with combination antidepressant-NSAID therapy
  • Infection risk with biologics for rheumatoid arthritis
  • Strongest FDA warning addressing risk of anaphylaxis is added to ferumoxytol labeling

Jul-August 2015 edition

  • Recent FDA Safety Communications  
  • Physician group endorses clinical pharmacists in the Emergency Department
  • New publications highlight the misuse and overuse of antibiotics

May-June 2015 edition

  • The White House Releases Plan to Combat Antibiotic-Resistant Bacteria
  • FDA Requests New Data on Health Care Antiseptics
  • Penicillin Allergies and Skin Testing: Implications for Antimicrobial Stewardship

Mar-April 2015 edition

  • Recommendations for pneumococcal vaccinations in adults 65 years and older      
  • Dosing of intravenous immunoglobulin G in obesity    
  • Warnings on sofosbuvir-amiodarone interaction and sharing of diabetes pens
  • Meta-analysis on proton pump inhibitor therapy for high-risk bleeding ulcers  

Jan-February 2015 edition

  • Sulfonamides and sulfite allergies: What is the difference?     
  • Interchangeability of posaconazole dosage forms  
  • FDA draft guidance for drug compounding and repackaging
  • Medicare’s oversight of compounded sterile products in hospitals 
Top